Neuro-Oncology Reviews
Volume
28 Number 3
31 January 2026
Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 3, 31 January
Yu SP.
Editorial for the Special Issue
"Glioblastoma: What Do We Know?".
Cells.
2026 Jan 21;15(2):200. doi:
10.3390/cells15020200. PMID:
41597274. Editorial. ˍ
Hsu CY, Baig MR, Patel PN, Singh G, Abdelrahim IM, Kadhem M, Arora
V, Maddula VR, Nayak PP, Iqbal MS.
Innovative
approaches to irinotecan-based therapies for glioblastoma:
Advancements in drug delivery and combination strategies.
Crit
Rev Oncol Hematol. 2026 Jan 22;219:105144. doi:
10.1016/j.critrevonc.2026.105144. PMID:
41580174. Review˰ ˍ
Harbi E, Byrne YY, Bozbey HU, Tastekin D, Oncul O, Hosseiny S,
Yahya D, Yildiz O, Erdogan M, Slocum AK, Mason CE, Aschner M.
Enhancing the efficacy of VEGF
inhibitors by co-inhibition of HIF in the treatment of
glioblastoma.
Apoptosis.
2026 Jan 23;31(2):56. doi:
10.1007/s10495-026-02275-5. PMID:
41575610. Review. ˍ
Wu W, Chen W, Ma W, Wang Y.
Epigenetic
mechanisms and therapeutic advances in diffuse midline glioma
(Review).
Oncol
Rep. 2026 Jan 23;55(3):50. doi:
10.3892/or.2026.9055. PMID:
41574724. Review. ˍ
Panciani PP, Ius T, Lombardi G, Montemurro N, Agnoletti A, Altieri
R, Barbagallo GMV, Buglione M, Catapano G, Cavallo LM, Certo F,
d'Avella D, Denaro L, Della Pepa GM, De Maria L, Esposito V,
Fioravanti A, Garbossa D, Marton E, Merli R, Nodari G, Olivi A,
Frati A, Pignotti F, Raffa G, Raneri F, Sabatino G, Somma T,
Guerrini F, Spena G, Telera S, Tomasi C, Trevisi G, Zanin L,
Fontanella MM, Angileri FF.
Surgical
treatment of recurrent glioblastoma: a multicenter perspective
from the Italian society of neurosurgery (SINch®)
and a systematic review.
Neurosurg
Rev. 2026 Jan 27;49(1):163. doi:
10.1007/s10143-025-04104-w. PMID:
41591525. Review˰ ˍ
Alomari O, Güney B, Juhmani RA, Alrabadi B, Mokresh ME,
Odabas H, Alomari T, Reiter RJ.
Melatonin
in glioblastoma therapy: clinical promise and mechanistic insights
from bench to bedside.
Neurosurg
Rev. 2026 Jan 28;49(1):165. doi:
10.1007/s10143-025-04121-9. PMID:
41604009. Review˰ ˍ
Wang M, Wu C, Zhang Z, Li X, Liao J, Zhang M, Jian E, Yu X, Zhu Y,
Cai P.
A bibliometric analysis of
progress and trends in pediatric glioma research.
Discov
Oncol. 2026 Jan 28;17(1):346. doi:
10.1007/s12672-026-04445-y. PMID:
41606399. Bibliometric analysis. ˍ
Parekh D, Patel AH, Khan A, Olojakpoke E, Karpe A, Peelay Z, Patil
V.
CAR-T in relapsed refractory
high-grade glioma and glioblastoma - who, what, when and how?
Ecancermedicalscience.
2025 Sep 30;19:2001. doi:
10.3332/ecancer.2025.2001. PMID:
41561543. Review. ˍ
Barjij I, Meliani M.
Cancer stem cells
and post-therapy tumour recurrence: a systematic review of
mechanistic pathways and translational
gaps.
Ecancermedicalscience.
2025 Oct 16;19:2016. doi:
10.3332/ecancer.2025.2016. PMID:
41561527. Review. ˍ
Cueto-Ureña C, Ramírez-Expósito MJ,
Martínez-Martos JM.
Neuron-Glioma
Synapses in Tumor Progression.
Biomedicines.
2025 Dec 29;14(1):72. doi:
10.3390/biomedicines14010072. PMID:
41595608. Review. ˍ
Khafaga DSR, Basem Y, AlAtar HM, Sherif A, Ata A, Sabry F,
El-Morsy MT, Attia SS.
Cancer
Neuroscience: Linking Neuronal Plasticity with Brain Tumor Growth
and Resistance.
Biology
(Basel). 2026 Jan 6;15(2):108. doi:
10.3390/biology15020108. PMID:
41594844. Review. ˍ
Rahman MA, Yadab MK, Ali MM.
Therapeutic
Advances of Curcumin and Nanocurcumin in Glioblastoma: Molecular
Targets, Bioavailability, and Drug Delivery.
Nutrients.
2026 Jan 7;18(2):194. doi:
10.3390/nu18020194. PMID:
41599806. Review. ˍ
Agarwal S, Han S, Lal A, Vira V, Chandla A, Mehranpour P, Yang I,
Wadehra M.
A Comprehensive Review of
Immunotherapeutic Modalities in Glioblastoma: Mechanisms,
Efficacy, and Safety Considerations.
Cancers
(Basel). 2026 Jan 9;18(2):212. doi:
10.3390/cancers18020212. PMID:
41595133. Review. ˍ
Jadoon S, Solou M, Moussa AA, Zisakis A.
Intracranial
primary collision tumours: A comprehensive systematic review on
preoperative radiological accuracy and neuro-oncological insights.
Brain
Spine. 2026 Jan 12;6:105943. doi:
10.1016/j.bas.2026.105943. PMID:
41584996. Review. ˍ
Dabbagh Ohadi MA, Soleimani S, Kakoienejad MM, Ghasemi M,
Hadjipanayis CG.
Clinical benefits of
photodynamic therapy in glioblastoma: systematic review and
meta-analysis.
J
Neurosurg. 2026 Jan 16:1-11. doi:
10.3171/2025.8.JNS25763. PMID:
41569684. Review; Meta-analysis˰
ˍ
Shao D, Lou S, Liu Y, Kou Z.
Artificial
intelligence in glioma research: a bibliometric analysis of global
trends, hotspots, and future directions.
Front
Neurol. 2026 Jan 12;16:1701499. doi:
10.3389/fneur.2025.1701499. PMID:
41603012. Bibliometric analysis. ˍ
Dynarowicz K, Smolak B, Bartusik-Aebisher D, Guz W, Henrykowska G,
Aebisher D.
Current
Pharmacotherapeutic Strategies in Diffuse Gliomas: Focus on
Glioblastoma, IDH-Wildtype, and Emerging Targeted Therapies for
IDH-Mutant Tumors.
Pharmaceuticals
(Basel). 2026 Jan 14;19(1):148. doi:
10.3390/ph19010148. PMID:
41599746. Review. ˍ
Kim DJ.
Molecular and Immune
Mechanisms Governing Cancer Metastasis, Including Dormancy,
Microenvironmental Niches, and Tumor-Specific Programs.
Int
J Mol Sci. 2026 Jan 15;27(2):875. doi:
10.3390/ijms27020875. PMID:
41596524. Review. ˍ
Fiallo Arroyo J, Leon-Rojas JE.
The
Glymphatic-Immune Axis in Glioblastoma: Mechanistic Insights and
Translational Opportunities.
Int
J Mol Sci. 2026 Jan 16;27(2):928. doi:
10.3390/ijms27020928. PMID:
41596575. Review. ˍ
Rubio C, Pérez-Villavicencio J, Esteban-Román NF,
Lee Á, Reyes-Soto G, Rubio-Osornio M.
The
Extracellular Matrix, the Silent 'Architect' of Glioma.
Biomedicines.
2026 Jan 17;14(1):205. doi:
10.3390/biomedicines14010205. PMID:
41595739. Review. ˍ